These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

978 related items for PubMed ID: 22578915

  • 21. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
    Toni D, Ahmed N, Anzini A, Lorenzano S, Brozman M, Kaste M, Mikulik R, Putaala J, Wahlgren N, SITS investigators.
    Neurology; 2012 Mar 20; 78(12):880-7. PubMed ID: 22402853
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Outcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: initial experience of a community-based hospital in a developing country.
    Muengtaweepongsa S, Dharmasaroja P, Kummark U.
    J Stroke Cerebrovasc Dis; 2012 Jan 20; 21(1):42-6. PubMed ID: 22225863
    [Abstract] [Full Text] [Related]

  • 27. Mild stroke: safety and outcome in patients receiving thrombolysis.
    Logallo N, Kvistad CE, Naess H, Waje-Andreassen U, Thomassen L.
    Acta Neurol Scand Suppl; 2014 Jan 20; (198):37-40. PubMed ID: 24588505
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry.
    Matsuo R, Kamouchi M, Ago T, Hata J, Shono Y, Kuroda J, Wakisaka Y, Sugimori H, Kitazono T, FSR investigators.
    Geriatr Gerontol Int; 2014 Oct 20; 14(4):954-9. PubMed ID: 24320947
    [Abstract] [Full Text] [Related]

  • 31. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience.
    Simon JE, Sandler DL, Pexman JH, Hill MD, Buchan AM, Calgary Stroke Programme.
    Age Ageing; 2004 Mar 20; 33(2):143-9. PubMed ID: 14960429
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Analyses of the Turkish National Intravenous Thrombolysis Registry.
    Kutluk K, Kaya D, Afsar N, Arsava EM, Ozturk V, Uzuner N, Giray S, Topcuoglu MA, Gungor L, Sirin H, Yaka E, Ozdemir O, Dalkara T, Turkish Thrombolysis Study Group.
    J Stroke Cerebrovasc Dis; 2016 May 20; 25(5):1041-1047. PubMed ID: 26853139
    [Abstract] [Full Text] [Related]

  • 35. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L, La Gioia S, Ghidinelli C, Anzalone N, De Filippis C, Comi G.
    J Stroke Cerebrovasc Dis; 2013 Aug 20; 22(6):703-8. PubMed ID: 22133742
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 49.